Showing 2321-2330 of 2656 results for "".
- Vitamin Sciences Lauches Visivite Blue Light Basher Ocular Supplementhttps://modernod.com/news/vitamin-sciences-lauches-visivite-blue-light-basher-ocular-supplement/2478604/Vitamin Science has added to its arsenal of quality ocular supplements with its launch of VisiVite Blue Light Basher earlier this year. High energy blue light is everywhere—cell phones, TV’s, LED lights and sunlight itself. To
- Kodiak Sciences Completes Enrollment of Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet AMDhttps://modernod.com/news/kodiak-sciences-completes-enrollment-of-phase-2b-3-pivotal-study-of-ksi-301-in-patients-with-wet-amd/2478561/Kodiak Sciences announced that recruitment has concluded in its DAZZLE pivotal study of KSI-301, Kodiak’s anti-VEGF antibody biopolymer conjugate, in patients with wet age-related macular degeneration (AMD). DAZZLE was planned to enroll 550 treatment-naïve patients worldwide; the target enr
- Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical Studyhttps://modernod.com/news/gemini-therapeutics-announces-gem103-meets-all-endpoints-in-phase-1-clinical-study/2478546/Gemini Therapeutics announced that the phase 1 study of GEM103, the company’s investigational treatment for dry AMD, met all its endpoints. Results demonstrate that in 12 patients receiving a single intravitreal (IVT) injection of GEM103, there were no dose-limiting toxicities or treatment-
- CDC Now Says Wearing a Mask Protects the Wearer, Toohttps://modernod.com/news/cdc-now-says-wearing-a-mask-protects-the-wearer-too/2478538/For months it has been clear that wearing a face mask reduces the transmission of COVID-19, because it prevents your respiratory droplets from spreading and potentially infecting other people. Now the Centers for Disease Control has highlighted another benefit of mask-wearing that many hoped or s
- Zeiss Presents Integrated Workflow Advancements at AAOhttps://modernod.com/news/zeiss-presents-integrated-workflow-advancements-at-aao/2478534/The Medical Technology segment of Zeiss will present its latest integrated diagnostic and surgical advancements at the 2020 American Academy of Ophthalmology’s (AAO) Annual Meeting taking place virtually from Nov. 13-15. Zeiss will also be hosting multiple indu
- Russia Says COVID-19 Vaccine Sputnik V 92% Effective in Late-Stage Studyhttps://modernod.com/news/russia-says-covid-19-vaccine-sputnik-v-92-effective-in-late-stage-study/2478524/Interim results from a phase 3 study of the Gamaleya Institute’s COVID-19 vaccine Sputnik V suggest that it had an efficacy rate of 92% after the second dose, the Russian Direct Investment Fund (RDIF) announced Wednesday. The data come after 20 confirmed cases of coronavirus were recorded 2
- Avellino Introduces Multiplex Respiratory Panel for Simultaneous Detection of COVID-19 and Influenzahttps://modernod.com/news/avellino-introduces-multiplex-respiratory-panel-for-simultaneous-detection-of-covid-19-and-influenza/2478505/Avellino announced that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which has been validated following the FDA’s Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing CLIA guidelines. The AvellinoCoV
- Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continueshttps://modernod.com/news/suspected-control-group-participant-in-astrazeneca-covid-19-vaccine-study-dies-trial-continues/2478449/Brazilian health authority Anvisa said that a participant in a clinical trial there of AstraZeneca’s experimental COVID-19 vaccine AZD1222 died earlier this week, but added that the study would nevertheless go on. AstraZeneca stated it cannot comment on individual cases because of confident
- Bausch Health and BHVI Announce Global Licensing Agreement For Myopia Control Contact Lenshttps://modernod.com/news/bausch-health-and-bhvi-announce-exclusive-global-licensing-agreement-for-myopia-control-contact-lens/2478422/Bausch Health has acquired an exclusive license for a myopia control contact lens design developed by BHVI, an Australian not-for-profit organization with an international focus on vision research. Terms of the deal were not disclosed. Bausch + Lomb will pair BHVI’s novel cont
- J&J Pauses COVID-19 Vaccine Studies After “Unexplained Illness”https://modernod.com/news/jj-pauses-covid-19-vaccine-studies-after-unexplained-illness/2478407/Johnson & Johnson confirmed that it paused further dosing in all clinical studies of its COVID-19 vaccine candidate JNJ-78436735, including the phase 3 ENSEMBLE trial, due to an “unexplained illness” in a participant. The company noted that the subject’s illness is being rev